About BCF Life Sciences
BCF Life Sciences is a company based in Pleucadeuc (France) founded in 1986 was acquired by MBO & Co in June 2018. BCF Life Sciences offers products and services including Kera-Diet®, Free Amino Acids, and Plant Biostimulant Solutions. BCF Life Sciences operates in a competitive market with competitors including GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
- Headquarter Pleucadeuc, France
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$170.15 K (USD), Grant
Nov 01, 2023
-
Investors
European Union
& 1 more
-
Employee Count
Not available
-
Acquired by
MBO & Co
(Jun 21, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BCF Life Sciences
BCF Life Sciences offers a comprehensive portfolio of products and services, including Kera-Diet®, Free Amino Acids, and Plant Biostimulant Solutions.
Supplement supporting hair and nail growth through amino acids.
Essential building blocks for proteins in health applications.
Natural amino acids enhancing plant growth and sustainability.
People of BCF Life Sciences
Unlock access to complete
Funding Insights of BCF Life Sciences
Investors in BCF Life Sciences
BCF Life Sciences has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union and MBO+.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment support is provided to managers and entrepreneurs by MBO+.
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for BCF Life Sciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by BCF Life Sciences
Investment portfolio details for BCF Life Sciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - BCF Life Sciences
Detailed financials for BCF Life Sciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bcf Life Sciences Comparisons
Peer comparison for BCF Life Sciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of BCF Life Sciences
BCF Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GSK, Avidity Biosciences, Sutro Biopharma, Antheia and Vividion Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| Locked | Locked | Locked |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| Locked | Locked | Locked |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| Locked | Locked | Locked |
Yeast cells are genetically engineered to produce medicinal products.
|
|
| Locked | Locked | Locked |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| Locked | Locked | Locked |
CRISPR-engineered cell and gene therapies are developed for research applications.
|
Detailed competitors of BCF Life Sciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bcf Life Sciences
Complete news archive for BCF Life Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BCF Life Sciences
BCF Life Sciences was founded in 1986 and raised its 1st funding round 37 years after it was founded.
BCF Life Sciences is headquartered in Pleucadeuc, France. It is registered at Pleucadeuc, Morbihan, France.
BCF Life Sciences was established in 1986 in Pleucadeuc, France, within the life sciences sector. Operations center on the production of natural amino acids such as L-Cystine and L-Tyrosine, along with derivatives including Carbocisteine. Non-allogenic proteins are supplied to pharmaceutical and healthcare industries, while highly digestible proteins support human, animal, and plant nutrition. A dedicated RD team of six engineers conducts nearly 4000 analyses monthly using 80 physicochemical methods.
BCF Life Sciences's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
BCF Life Sciences offers Kera-Diet®, Free Amino Acids, and Plant Biostimulant Solutions.
BCF Life Sciences has 2 investors. Key investors include European Union, and MBO+.